Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.44 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.44 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.44 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.44 |
| ▸ | P2RY6 | Q15077 | 9/20 | 0.39 |
| ▸ | TK1 | P04183 | 1/20 | 0.34 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.34 |
| ▸ | DUT | P33316 | 2/20 | 0.33 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.33 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27451524 | 1.00 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL51723 | 0.84 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL28786348 | 0.84 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL9805678 | 0.83 | P2RY6 (0.50) | P2RY6DUTP2RY2P2RY4 | |
| Hydrochloric Acid SCHEMBL27782735 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL414705 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL27703606 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2242410 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL65485 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2009955 | 0.82 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2959 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630593-B2 | Method of killing leukemia cells by administration of recombinant'Y3 proteins | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-05-19 | — | — | US | claimed |
| EP-4558641-A1 | METHODS FOR DETECTION AND REDUCTION OF SAMPLE PREPARATION-INDUCED METHYLATION ARTIFACTS | Guardant Health, Inc. (US) | 2025-05-28 | — | — | EP | claimed |
| CN-119923475-A | Method for detecting and reducing sample preparation induced methylation artifacts | 夸登特健康公司 | 2025-05-02 | — | — | CN | claimed |
| EP-4086250-B1 | MULTIFUNCTIONAL INHIBITORS OF MEK/PI3K AND MTOR/MEK/PI3K BIOLOGICAL PATHWAYS AND THERAPEUTIC METHODS USING THE SAME | UNIV MICHIGAN REGENTS (US) | 2024-12-11 | — | — | EP | claimed |
| CN-118488841-A | Combination of PRMT5 inhibitor and anticancer therapeutic agent | 南京再明医药有限公司 | 2024-08-13 | — | — | CN | claimed |
| WO-2024020573-A1 | METHODS FOR DETECTION AND REDUCTION OF SAMPLE PREPARATION-INDUCED METHYLATION ARTIFACTS | GUARDANT HEALTH, INC. (US) | 2024-01-25 | — | — | WO | claimed |
| WO-2023225608-A1 | METHODS FOR ABLATING MYELOID DERIVED SUPPRESSOR CELLS USING NEO-201 ANTIBODY | PRECISION BIOLOGICS, INC. (US) | 2023-11-23 | — | — | WO | claimed |
| US-20230272019-A1 | FUNGAL GLYCAN BINDING PROTEIN WHICH POSSESSES ANTIVIRAL AND ANTICANCER ACTIVITY | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-08-31 | — | — | US | claimed |
| CN-116407503-A | Blank liposome composition with pentacyclic triterpene compound as membrane material, and preparation method and application thereof | 复旦大学 | 2023-07-11 | — | — | CN | claimed |
| US-20230110614-A1 | HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A RESPIRATORY VIRUS | ATOSSA THERAPEUTICS, INC. | 2023-04-13 | — | — | US | claimed |
| WO-1987001935-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA VITHAL J | 1987-04-09 | — | — | WO | claimed |
| US-4585736-A | Flow cytometric measurement of total DNA and incorporated halodeoxyuridine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-04-29 | — | — | US | claimed |
| US-4444762-A | Vehicle composition containing 1-substituted azacyclopentan-2-ones | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1984-04-24 | — | — | US | claimed |
| US-4424210-A | Vehicle composition containing 1-substituted azacycloalkan-2-ones | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1984-01-03 | — | — | US | claimed |
| US-4423040-A | Vehicle composition containing 1-substituted azacyclohexan-2-ones | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1983-12-27 | — | — | US | claimed |
| US-4415563-A | TOPICAL APPLICATION OF MEDICINE; COSMETICS | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1983-11-15 | — | — | US | claimed |
| US-4316893-A | USED FOR TOPICAL APPLICATION WITH A PHYSIOLOGICALLY ACTIVE AGENT | NELSON RESEARCH & DEVELOPMENT CO. (US) | 1982-02-23 | — | — | US | claimed |
| US-3991203-A | Vehicle composition containing 1-substituted azacyclopentan-2-ones | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1976-11-09 | — | — | US | claimed |
| US-3989815-A | PENETRATION OF SKINS | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1976-11-02 | — | — | US | claimed |
| US-3989816-A | PENETRATION OF SKINS OR MEMBRANES | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1976-11-02 | — | — | US | claimed |